French Tribune |
Novartis says asthma blockbuster Xolair also effective against serious hives
FiercePharma But Novartis says in financial filings that its pricing is under pressure for the asthma treatment. In the U.K., the price watchdog NICE last fall indicated it might drop approval of the drug there but then relented in March after Novartis offered up … Novartis reports new Phase III data showing omalizumab significantly improves … Novartis skin drug helps patients with chronic hives Novartis' omalizumab effective for severe hives |
View full post on asthma – Google News